A carregar...
Regorafenib-associated hand–foot skin reaction: practical advice on diagnosis, prevention, and management
BACKGROUND: Regorafenib is an orally available, small-molecule multikinase inhibitor with international marketing authorizations for use in colorectal cancer and gastrointestinal stromal tumors. In clinical trials, regorafenib showed a consistent and predictable adverse-event profile, with hand–foot...
Na minha lista:
| Publicado no: | Ann Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4576906/ https://ncbi.nlm.nih.gov/pubmed/26034039 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdv244 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
A carregar...